Thyroid Cancer Drugs Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

The global thyroid cancer drugs market was valued at US$ 400.5 million in 2020 and is predicted to reach US$ 1,689.7 million by 2028; which is expected to experience a compound annual growth rate (CAGR) of 19.9% during the forecast period from 2021- 2028. Increasing incidences of thyroid cancer largely among women acts as a driving factor for the thyroid drugs market. Reports released by American Cancer Society out shows about 52070 cases of thyroid cancer were detected in the US and casualties accounted was 2170. Such incidences of cancer ascribed owing to family history for goiter, heredity diseases and radiation exposure. However, factors such as increasing awareness for the treatment of cancer, rising government aids and reimbursement pushes the market revenue growth.

Request for Sample Copy of this Research Report:
https://www.accurizemarketresearch.com/report/thyroid-cancer-drugs-global-scenario--market/sample-request

Proliferate practice of targeted therapies for treating thyroid cancer acts as a restraint for the thyroid cancer drugs market. Such therapies target at the specific cancer tissue or proteins which endorse the growth of cancer. These therapies have seen a significant usage for the treatment of cancer because hormone-based treatment, radioactive iodine therapy is feeble against such cancers. Further, drug rejection pertaining to its incompetence to provide effectual yield, higher treatment cost and generic drugs available are the prime reason restraining the market for thyroid cancer drug market.
Intensifying number of obese population and embracing of unhealthy lifestyle such as junk food and alcohol consumption further influences the thyroid cancer drug market. In addition, increasing R&D and funds by numerous organizations for the treatment, improving expenditure towards healthcare and government provision will boost the thyroid cancer drug market during the forecast period.
North American region accounts for highest revenue share owing to surge in the cases of thyroid cancer. Geographically, thyroid cancer drugs market segments into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America holds the dominant position in thyroid cancer drugs market owing to rising prevalence of thyroid cancer in this region. Following Asia- pacific is also anticipated for the market revenue share during the forecast period
Major players inducing the Global Thyroid Cancer Drugs Market are Mylan N.V., Abbott, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, AstraZeneca, GlaxoSmithKline plc, Eisai Co., Ltd, Takeda Pharmaceutical Company Ltd, Biovista, Cytori Therapeutics Inc, Bayer AG, Novartis AG, Jerome Stevens Pharmaceuticals Inc, Baxter, Celgene Corporation, Bio-Path Holdings, Inc. and Vascular Biogenics among others.

Global Thyroid Cancer Drugs Market Segmentation

By Type
• Thyroid cancer
• Hurthle cell cancer
• Follicular thyroid cancer
• Anaplastic thyroid cancer
• Medullary thyroid cancer (MTC)
By Treatment
• Medication
• Radioactive iodine (radioiodine) therapy
• Hormone therapy
• Chemotherapy
• Surgery
o Near-total thyroidectomy
o Total thyroidectomy and lobectomy
By Drug Type
• Ipilimumab
• Cabozantinib-S-Malate
• Caprelsa (Vandetanib)
• Doxorubicin Hydrochloride
• Cometriq (Cabozantinib-S-Malate)
• Lenvatinib Mesylate
• Nivolumab
• Vandetanib
• Others
By End Users:
• Hospitals
• Oncology Clinics
• Research Organizations
• Others
By route of administration
• Injectable
• Oral
• Others

By Region
• North America
o US
o Canada
o Rest of North America
• Europe
o UK
o Germany
o France
o Spain
o Italy
o Rest of Europe (RoE)
• Asia Pacific
o Japan
o China
o India
o Rest of Asia Pacific
• Rest of the World (RoW)
o South & Central America
o Middle East
o Africa

Request For Customized report:
https://www.accurizemarketresearch.com/report/thyroid-cancer-drugs-global-scenario--market/ask-for-customization

Contact:
Rakesh K Singh
Head - Business Development
Patna Office (Asia):
K-129, PC Colony, Hanuman Nagar, Kankarbagh, Patna,
PIN - 800020
Tel: +1-339-368-6383/ +91-9665120699
Email: help@accurizemarketresearch.com
Web: https://www.accurizemarketresearch.com/
Accurize Market Research Blog:
https://www.accurizemarketresearch.com/blog-list

About Accurize Market Research-
Accurize Market Research (AMR) is a full-service market research and business-consulting company which provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.” Destined by the dedicated team of analysts and experts, we are envisioned to provide you our best in order to plan your next strategic across several industry verticals.
We at Accurize Market Research provide syndicated as well as customized reports across domains namely Consumer Goods, Food & Beverages, Manufacturing, Medical Devices, Mining Equipment, Automation, Manufacturing, Healthcare & Medical, and Defense & Aerospace, Semiconductor & Electronics, Construction, Information and Communication, Construction, Banking, Financial Services and Insurance (BFSI), and Energy among others. These industry vertical areas are further studied and analyzed across different geographies namely North America, Europe, Asia Pacific and Rest of the World (RoW). The countries across these major geographies are also covered under the scope of our study; such as the U.S., Mexico and Canada under North America; UK, Germany, Russia, Germany and France among others under Europe. Similarly, China, India, Taiwan, South Korea, Australia, Singapore and Japan among others are covered under Asia Pacific. Rest of the World (RoW) includes South & Central America, Middle East and Africa. Further, as per the scope countries across South & Central America, Middle East and Africa would also be studied separately under the scope of the report.
Available Report Format: Excel/PDF/PPT/Word

This release was published on openPR.